Market Value224,217,000
Total Holdings96
File Date2021-08-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
STXS / Stereotaxis, Inc.
OTIC / Otonomy Inc
AYLA / Ayala Pharmaceuticals Inc
KYG5960S1241 / Medicus Sciences Acquisition Corp.
APTO / Aptose Biosciences Inc.
BIIB / Biogen Inc.
CHRS / Coherus Oncology, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
ATNM / Actinium Pharmaceuticals, Inc.
ARDX / Ardelyx, Inc.
EVGN / Evogene Ltd.
MRUS / Merus N.V.
AKRO / Akero Therapeutics, Inc.
BNTC / Benitec Biopharma Inc.
MSAC / Medicus Sciences Acquisition Corp - Class A
VSTM / Verastem, Inc.
MDNA / Medicenna Therapeutics Corp
CHAQ.WS / Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
TCRR / Tcr2 Therapeutics Inc
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
ADMS / Adamas Pharmaceuticals Inc
IMGN / ImmunoGen, Inc.
SAGE / Sage Therapeutics, Inc. Call
ETON / Eton Pharmaceuticals, Inc.
ALDX / Aldeyra Therapeutics, Inc.
GMDA / Gamida Cell Ltd.
SGEN / Seagen Inc
ITCI / Intra-Cellular Therapies, Inc.
LPTX / Leap Therapeutics, Inc.
/ RENALYTIX AI PLC-ADR DEPOSITARY RECEIPT
HALO / Halozyme Therapeutics, Inc.
VIRX / Viracta Therapeutics, Inc.
BHVN / Biohaven Ltd.
KALA / KALA BIO, Inc.
DNAB / Social Capital Suvretta Holdings Corp II
RLMD / Relmada Therapeutics, Inc.
INSM / Insmed Incorporated
PHGE / BiomX Inc.
CLRB / Cellectar Biosciences, Inc.
VCEL / Vericel Corporation
KDNY / Chinook Therapeutics Inc
/ Therapeutics Acquisition Corp. Class A
LRMR / Larimar Therapeutics, Inc.
SURF / Surface Oncology Inc
PIRS / Pieris Pharmaceuticals, Inc.
MCRB / Seres Therapeutics, Inc. Call
VTGN / Vistagen Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
SLRX / Salarius Pharmaceuticals, Inc.
MLTX / MoonLake Immunotherapeutics
ODT / Odonate Therapeutics Inc
ONCR / Oncorus, Inc.
KYG5960S1167 / Medicus Sciences Acquisition Corp. Unit
JNCE / Jounce Therapeutics Inc
SLNO / Soleno Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
CYCC / Bio Green Med Solution, Inc.
WVE / Wave Life Sciences Ltd. Call
CERE / Cerevel Therapeutics Holdings, Inc.
DRNA / Dicerna Pharmaceuticals Inc
DNAC / Social Capital Suvretta Holdings Corp III
DNAA / Social Capital Suvretta Holdings Corp I
TRIL / Trillium Therapeutics Inc
AFMD / Affimed N.V.
CALA / Calithera Biosciences, Inc.
DNAD / Social Capital Suvretta Holdings Corp IV - Class A
RAPT / RAPT Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
RXDX / Prometheus Biosciences Inc
APLS / Apellis Pharmaceuticals, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
CRIS / Curis, Inc.
ELOX / Eloxx Pharmaceuticals, Inc.
RACB / Research Alliance Corp II - Class A
RCUS / Arcus Biosciences, Inc. Put
ARNA / Arena Pharmaceuticals Inc
ATXS / Astria Therapeutics, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
TPTX / Turning Point Therapeutics Inc
GH / Guardant Health, Inc.
CCXI / ChemoCentryx Inc
CCXI / ChemoCentryx Inc Put
ATHA / Athira Pharma, Inc.
MCRB / Seres Therapeutics, Inc.
VRAYQ / ViewRay, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
FMTX / Forma Therapeutics Holdings Inc
NXTC / NextCure, Inc.
HZNP / Horizon Therapeutics Plc
CGEM / Cullinan Therapeutics, Inc.
PYPD / PolyPid Ltd.
EPIX / ESSA Pharma Inc.
ISEE / IVERIC bio Inc
SRRA / Sierra Oncology Inc
SRRK / Scholar Rock Holding Corporation
MORF / Morphic Holding, Inc.
ARVN / Arvinas, Inc.
BLU / Bellus Health Inc
IMVT / Immunovant, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
RETA / Reata Pharmaceuticals Inc - Class A
IMTX / Immatics N.V.
COGT / Cogent Biosciences, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
CLDX / Celldex Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
BIIB / Biogen Inc. Call
RCKT / Rocket Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
QURE / uniQure N.V.
CERS / Cerus Corporation
VCYT / Veracyte, Inc.
ETNB / 89bio, Inc.
CGEN / Compugen Ltd.
VRDN / Viridian Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
UTHR / United Therapeutics Corporation
ACRS / Aclaris Therapeutics, Inc.
MGNX / MacroGenics, Inc.
DCTH / Delcath Systems, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
WVE / Wave Life Sciences Ltd.